Bioxyne Limited (ASX:BXN)
0.0250
0.00 (0.00%)
Jun 6, 2025, 2:04 PM AEST
Revenue by Product
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
Plant Based | 5.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Plant Based Growth | 6.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufacture/Sales | 3.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Wholesale | 886.91K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Wholesale Growth | 1984.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Direct | 104.69K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Direct Growth | 3825.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | NaN - NaN |
---|---|---|---|---|---|---|
United Kingdom/Europe/Japan | 5.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom/Europe/Japan Growth | 6.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Australia | 3.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 886.91K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 1984.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 104.69K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | 3825.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Australia/New Zealand | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Australia/New Zealand Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|